In contrast, the expression of β2‐adrenergic receptor (ADRβ2) which accounts for ~20% of all cardiac β‐adrenoreceptors,33 and whose activation increases contractile force and heart rate, is not altered in DMD cardiomyocytes. This evidence concerns the gene ADRB2 and Duchenne muscular dystrophy.